Bristol-Myers Squibb Company (BMY) Q3 2026 earnings results
Bristol-Myers Squibb Company (BMY) reported Q3 2026 results on Oct 29, 2026, 7:05:52 AM ET: adjusted EPS $1.35 vs. $1.22 expected (beat by 10.3%); revenue $13.07B vs. $12.73B expected (beat by 2.7%). Outlook: Raising 2026 revenue guidance to $49.75 billion to $50.25 billion and updating non-GAAP EPS range to $6.35 to $6.55.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $1.35 | $1.22 | Beat by 10.3% |
| Revenue | $13.07B | $12.73B | Beat by 2.7% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Oct 29, 2026, 7:05:52 AM ET. Nexqual published them 48 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 6.9% from $12.22B.
Stock reaction
The results came out before the market opened. BMY closed at $61.39 on October 29, 2026, up 1.4% from its $60.57 close on October 28, 2026 before the results.
Questions and answers
Did Bristol-Myers Squibb Company beat earnings expectations?
Yes. Bristol-Myers Squibb Company reported adjusted EPS of $1.35 against an average analyst estimate of $1.22 (beat by 10.3%), and revenue of $13.07B against $12.73B expected (beat by 2.7%).
What were Bristol-Myers Squibb Company's Q3 2026 earnings and revenue?
adjusted diluted EPS of $1.35 and revenue of $13.07B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 6.9% from $12.22B.
When did Bristol-Myers Squibb Company report Q3 2026 earnings?
Oct 29, 2026, 7:05:52 AM ET, in an SEC 8-K filing (Item 2.02).
How did BMY stock react to the earnings?
The results came out before the market opened. BMY closed at $61.39 on October 29, 2026, up 1.4% from its $60.57 close on October 28, 2026 before the results.
What did Bristol-Myers Squibb Company say about its outlook?
Raising 2026 revenue guidance to $49.75 billion to $50.25 billion and updating non-GAAP EPS range to $6.35 to $6.55.
More on BMY
BMY stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 29, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:07 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:07 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt